Bronchiectasis Case Study

Acute bronchitis is one of the most common diagnoses encountered in a primary care setting. It affects millions of individuals resulting in significant impact on health of patients and health care industry. Studies have shown that 90% of times acute bronchitis is caused by a virus, yet health care providers are failing to treat or manage these patients with appropriate therapies (Knutson & Braun, 2002). The focus of this paper is to review the guidelines for treatment of acute bronchitis after differentiating acute bronchitis from other common respiratory disease in terms of epidemiology, pathophysiology, clinical features, diagnosis, differential diagnosis, complications and patient education. Understanding the evaluation and treatment guidelines, nurse practitioners can provide evidence-based practice for patients with acute bronchitis.

What clinical findings correlate with M.K.’s chronic bronchitis? What type of treatment and recommendations would be appropriate for M.K.’s chronic bronchitis?

Bronchitis is the inflammation of the mucous membranes of the bronchi, the airways that carry airflow from the trachea into the lungs. The thin mucus lining of these airways can become irritated and swollen; the cells that make up the lining may leak fluids in response to the inflammation. Bronchitis most often occurs during the cold and flu season usually coupled with an upper respiratory infection. Bronchitis can be divided into two categories: acute or chronic each of which has distinct etiologies, pathologies, and therapies. I chose this condition because it seemed like an interesting topic to research on, and I am also interested in learning more

Accordingly, to this information of COPD: Coping with COPD from PubMed Health, this article provides the early stages, progression, coping and emergency plan and this disease affects family and friends. It is written answering the question, what to expect from COPD and how to manage this lung disease? A team of health care professionals, scientists and editors, and experts (Chronic obstructive pulmonary disease (COPD), 2015), provides education of how this disease may affect daily lives, how to live with this disease and what causes

HPI: Margaret Elliot is a 52-year-old Caucasian female that is presenting with shortness of breath that has recently worsen. Mrs. Elliot states that her problems began 20 years ago when she had bronchitis, which she consistently has 2-3 times a year. She said that her symptoms have been getting worse the last 2.5 month, but have severely worsen over the past three days. She states that it has been restricting her daily activities and has been troubling her while sleeping lying down. She states that her symptoms improve alittle when she takes her medications. She also states that her symptoms worsen when she tries to walk across the room

A type of bronchodilator, aminophylline is a type of muscle relaxation medicine that helps lungs and chest circulate oxygen better. It is used to treat and prevent wheezing, restricted breathing and shortness of breath. The medicine is usually prescribed to those with bronchitis, asthma and lung diseases. As this medication requires a prescription, it is very important for a user to follow the instructions prescribed and take only at the times and the amount prescribed by his or her physician. Aminophylline can be in the form of liquid syrup, a pill or a cream. How this drug works is by making the lungs less sensitive to any allergens or foreign substances that may be inhaled, thus causing the muscles to relax in the chest and lungs and opening up the air passages so that breathing can be easier. It also increases the contractions in the diaphragm which aids better breathing patterns.

What clinical findings correlate with M.K.’s chronic bronchitis? What type of treatment and recommendations would be appropriate for M.K.’s chronic bronchitis?

History of Present Illness: Ms. Babula is a very pleasant 76-year-old woman who was previously seen in this office by Elvira Aguila, MD for moderate COPD by pulmonary function testing in 2010. She is currently on monotherapy with Atrovent p.r.n. and she has not used her bronchodilators for quite some time. She does have some stable dyspnea on exertion, which does not limit any of her activities. She does take care of an 18-month-old child as well. She denies any cough, though she does feel that she has some chest congestion in the morning. She denies any chest pain or wheezing.

Mr. Joseph is a 56-year-old has 30 smoking pack years. He was diagnosed 10 years ago with asthma/chronic bronchitis, arthritis of the knees, and congestive heart failure (CHF). Mr. Joseph weighs 350 pounds with a height of 6 feet, making his body mass index (BMI) of 47.5, much more than the recommended 25, and in fact his BMI places him in the morbid obesity classification. He takes medicines for his pulmonary conditions, along with a diuretic.

Bronchiolitis is a lower respiratory infection caused commonly by the respiratory syncytial virus (RSV) in the first two years of life. Nearly every child in the United States will be infected with RSV before its second birthday. The condition is a leading cause of hospital admissions among children under the age of two. The populations most frequently and severely affected by bronchiolitis include; infants less than 12 months of age, children born at a low gestational age (less than 32 weeks), and children with chronic lung disease, congenital heart disease, or immunodeficiency. Standardized and proper diagnosis and management are essential to effective treatment. The guideline established by the Academy of Pediatrics (AAP) in 2014 provides practitioners with recommendations for diagnosis, management, and prevention of bronchiolitis in children.

If all methods, mentioned in the previous article about bronchitis curing, are not helpful, it is time to take meaningful steps. However, only pediatrician can prescribe all drugs. Never make experiments and self-medicate. If you see, the situation is getting worse, call for a doctor.

Based on the findings from the case study was R.S has been a smoker for many years. One of the most significant risk factors for determining COPD is cigarette smoking. In determining this we need to the amount he has smoked as well as how often he has smoked that lead to the chronic bronchitis. What that means is that the airway mainly the bronchi is inflamed. Since it is chronic, which is a specific condition has been occurring for many years. This kind of diagnosis can lead to the coronary artery disease and peripheral arterial vascular disease.

Bronchiolitis is defined by the textbook as, “a diffuse, inflammatory obstruction in the small airways or bronchioles occurring most commonly in children” (Heuther & McCance, 2012). It is an acute inflammatory disease of the lower respiratory tract that occurs most commonly in infants and is caused by infection with seasonal viruses such as respiratory synctial virus (RSV) (Zorc & Hall, 2010). Bronchiolitis often results from an obstruction of the small airways. It is the leading cause of infant hospitalization in the United States (Zorc & Hall 2010) and is arguably the most common significant medical illness of childhood, with at least “1 in 7 normal infants developing symptomatic bronchiolitis in his or her first year of

Using the potential links on this page, answer the following questions specific to the information available in the linked sections:

This paper will discuss a case study of Liam, a three-month-old boy who is transferred from the General Practitioner (GP) to paediatric ward with bronchiolitis. Initially, Liam’s chief health issues will be identified, following by nursing assessment and diagnoses of the child’s need. Focus will be made on the management of two major health problems: respiratory distress and dehydration, and summary and evaluation of the interventions with evidence of learning. Lastly, a conclusion of author’s self-evaluation will be present.